This article was originally posted Feb. 14.

The Institute of Cancer Research in London said last month that it is setting up a new center to profile patient tumors using next-generation sequencing that will enable doctors "to develop treatment programs that are tailored to the specific DNA mutations driving a cancer, at that particular point in time."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.